跳至主要内容
临床试验/NCT02738099
NCT02738099已完成不适用

Risk Stratification of Patients Presenting With Cardiac Arrest

Essentia Health1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2016年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
100
试验地点
1
主要终点
Death from any cause

研究概览

简要总结

Method: Single center, prospective, non-randomized, unblinded case series of all patients presenting with a cardiac arrest. The proposed study will collect data on all comatose patients presenting with cardiac arrest. The primary end point is death from any cause at 30 days from admission.

Significance: Develop criteria to guide an invasive strategy for comatose patients presenting with cardiac arrest, and so avoid ineffective or even futile therapy which carry its own significant risks for patients in the future. The criteria, in turn, can serve as the basis for a prospective, randomized trial in the future.

详细描述

Research Design and Methods:

General Approach: This study is a prospective, non-randomized, unblinded case series of comatose patients presenting with cardiac arrest to either Essentia East (St. Mary's Medical Center or Miller-Dwan Medical Center) or Essentia West (Innovis Health).

Methods and Materials: Patients will be enrolled over a 60-month period by the PI, Sub-I, or study coordinator. The enrollment goal is 100 patients. The study will collect demographic, clinical and outcome data on comatose patients presenting with cardiac arrest only, and does not prescribe any clinical testing or therapies including PCI or hypothermia. All clinical decisions are left to the discretion of the attending providers.

Consent Process: This study will seek a waiver for informed consent as the patients, by study inclusion criteria, will not be able to provide informed consent, and this study uses a minimal risk design. In the spirit of transparency, attempts will be made to inform the patient, patient representative or family when possible of enrollment in the study within 48 hours of enrollment. The patient or appropriate patient representative identified from the EMR will be spoke to in person or by phone by the PI, sub-PI, or study coordinator.21 The patient and/or family will then have the opportunity to decline participation in the study. The conversation will be documented in the medical record by the PI, sub-PI or study coordinator.

Randomization Process: The study is a prospective, non-randomized, unblinded case series. Patient will be followed as a single cohort, and no randomization is required.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age greater than or equal to 18 years
  • Presumed cardiac etiology of arrest
  • GCS ≤ 819,20
  • Initial presentation to an outside facility or to the emergency room of the receiving facility.

排除标准

  • Presumed non-cardiac etiology of arrest including trauma, pulmonary embolus, sepsis, respiratory failure.
  • Transfer time from arrest to receiving facility greater than 12 hours
  • Cardiac arrest occurring after admission to either the outside facility or receiving facility.
  • Patient pronounced dead prior to arrival to the receiving facility emergency room.

结局指标

主要结局

Death from any cause

时间窗: 30 days

Death from any cause at 30 days from admission

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Michael Mollerus

MD

Essentia Health

研究点 (1)

Loading locations...

相似试验